Theresa Kelly

Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts

C. Moyes, D. Kelley, A. Cherrington, 2018, Diabetes.

Engineering Glucose Responsiveness Into Insulin

Margaret S. Wu, M. Erion, W. Seghezzi, 2017, Diabetes.

Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists

Margaret S. Wu, M. Erion, S. Hollingsworth, 2022, Nature Communications.

A glucose-responsive insulin therapy protects animals against hypoglycemia.

Margaret S. Wu, M. Erion, D. Kelley, 2018, JCI Insight.

Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic Index.

M. Erion, Fanyu Meng, S. Hollingsworth, 2022, Journal of medicinal chemistry.

Site-Selective Synthesis of Insulin Azides and Bioconjugates.

Xiaohong Zhu, Weijuan Tang, S. Krska, 2019, Bioconjugate chemistry.

A glucose-responsive insulin therapy protects animals against hypoglycemia.

Margaret S. Wu, M. Erion, D. Kelley, 2018, JCI insight.